Delivery Order SPE2DB22D2007-SPE2DB25FJ0JK

Award Date 4/1/25
Potential Completion Date 4/22/25
Potential Value $9.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,296.97 firm fixed-price delivery order is for the provision of TAVALISSE 150 MG TABLET 60S, with a period of performance through February 28, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,296.97 firm fixed-price delivery order is for the supply of TAVALISSE 150 MG TABLET 60S, a medication, with a completion date of February 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This is a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,266.70, is a delivery order for the drug Tavalisse 100 mg tablet 60s. The contract has an ultimate completion date of April 21, 2025 and is a firm fixed price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, with ID SPE2DB24D2101|SPE2DB25FKHNG, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has a Ceiling Value of $9,296.97. The contract is for the supply of TAVALISSE 150 MG TABLET 60S, a pharmaceutical product. The contract has an Ultimate Completion Date of April 1, 2025 and was awarded on March 11, 2025. The place of performance is...
This federal contract award is for the delivery of TAVALISSE 100 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $8,574.23. The contract is a Delivery Order with a Firm Fixed Price pricing type, awarded on November 6, 2024, with an ultimate completion date of November 29, 2024. The place of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,963.18 Firm Fixed Price delivery order contract covers the supply of TALVEY 40 MG/ML VIALML, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of April 9, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of pharmaceutical products, including the drug TIVDAK 40 MG VIALS. The award has a ceiling value of $27,898.01 and a completion date of November 13, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TAVNEOS 10 MG CAPSULE 180S, a pharmaceutical product. The contract has a ceiling value of $10,218.17 and runs through April 11, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,926.36 firm fixed-price delivery order covers the supply of "TALVEY 40 MG/ML VIALML" medical products, with a performance period through March 19, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $19,882.84 firm fixed price delivery order is for the supply of TIBSOVO 250 MG tablets. The contract has an ultimate completion date of May 14, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FJ0JK
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has an award ceiling value of $9,266.70 and is for the delivery of TAVALISSE 100 MG TABLET 60S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 22, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 7/1/25, 11:12 AM